News Second Theranos lab fails inspection, faces possibility of m... Sanctions could be imposed regardless of second lab closure.
News Avacta hoping to disrupt antibody drug dominance Avacta is one of several biotechs turning their backs on mabs.
News Abbott unveils next gen point of care diagnostics Abbott hopes for launch of its Alinity suite later this year.
News Theranos unveils new technologies, but concerns linger Desktop testing device and cloud-based diagnostic platform announced.
News Programmable lab-on-chip advancing in trials A digital device the size of a credit card could provide a diagnosis in just minutes for a huge range of conditions.
News Theranos appoints new execs, compliance board Under-fire diagnostics firm tightens regulatory and compliance efforts
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.